Bioventus Inc.BVSNASDAQ
Loading
Enterprise value to EBITDA ratio
5Y CAGR
-14.0%/yr
Long-term compound
Percentile
P42
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.16 | -71.4% |
| 2024 | 24.99 | +183.8% |
| 2023 | -29.82 | -561.7% |
| 2022 | -4.51 | -121.1% |
| 2021 | 21.39 | +40.7% |
| 2020 | 15.20 | -23.6% |
| 2019 | 19.89 | -12.8% |
| 2018 | 22.81 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |